What is Meconium Aspiration Syndrome (MAS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Meconium Aspiration Syndrome?

Meconium Aspiration Syndrome (MAS) is a clinical condition characterized by respiratory distress in newborns born through meconium-stained amniotic fluid, where the respiratory symptoms cannot be explained by other causes. 1, 2

Definition and Pathophysiology

MAS occurs when a neonate aspirates meconium (the first stool of a newborn) mixed with amniotic fluid into the lungs before, during, or immediately after birth. 3 This aspiration can happen during the antepartum or intrapartum periods and results in multiple pulmonary complications. 4

Mechanisms of Lung Injury

The aspiration of meconium causes respiratory distress through several distinct pathways:

  • Airway obstruction from thick meconium particles blocking the tracheobronchial airways 4
  • Chemical pneumonitis from the irritant properties of meconium components 4
  • Surfactant dysfunction leading to alveolar collapse and impaired gas exchange 4
  • Ventilation-perfusion mismatching causing severe hypoxemia 4
  • Persistent pulmonary hypertension often develops as a complication, particularly in infants who experienced chronic in utero stress with resultant thickening of pulmonary vessels 4

Epidemiology

  • Meconium-stained amniotic fluid occurs in approximately 5-15% of all deliveries 5
  • Only 3-5% of neonates born through meconium-stained amniotic fluid actually develop MAS 5
  • The condition is more common in post-term pregnancies (≥42 weeks gestation) 5
  • MAS remains an important cause of morbidity and mortality in term and post-term newborns despite advances in perinatal care 1, 6

Clinical Presentation

MAS should be suspected in any infant with respiratory distress born through meconium-stained amniotic fluid. 4 The clinical features include:

  • Early onset respiratory distress in term and near-term infants 2
  • Poor lung compliance requiring increased ventilatory support 2
  • Hypoxemia that may be severe and refractory 2
  • Radiographic findings showing hyperinflation and patchy opacifications on chest X-ray 2

Risk Factors and Timing

The aspiration can occur at different time points:

  • Before delivery during periods of fetal distress 3
  • During birth as the infant passes through the birth canal 3
  • During resuscitation if meconium is present in the airway 3

Complications

Beyond the immediate respiratory distress, MAS can lead to life-threatening complications:

  • Respiratory failure requiring mechanical ventilation 7
  • Pulmonary air leaks including pneumothorax 7
  • Persistent pulmonary hypertension of the newborn which significantly worsens prognosis 7, 4
  • Secondary pulmonary infection, as meconium in the airways predisposes to bacterial colonization despite being sterile itself 4

Current Understanding of Management

Historical approaches to MAS prevention have evolved significantly. 7 Routine suctioning of the oropharynx before delivery of the shoulders was abandoned after randomized controlled trials showed no benefit. 3 Similarly, routine endotracheal intubation and tracheal suctioning for all meconium-stained newborns was discontinued after evidence showed no value in vigorous infants. 3

For nonvigorous infants born through meconium-stained amniotic fluid, current guidelines no longer recommend routine immediate direct laryngoscopy with or without tracheal suctioning, as this delays ventilation without improving outcomes. 5, 8 Tracheal suctioning has not been associated with reduction in the incidence of MAS or mortality in depressed infants. 3

Long-term Considerations

Despite improved survival rates over recent decades due to advances in supportive care, surfactant therapy, inhaled nitric oxide, and high-frequency ventilation, long-term morbidity among survivors remains a significant concern. 1, 6

References

Research

Meconium aspiration syndrome: from pathophysiology to treatment.

Annals of medicine and surgery (2012), 2024

Research

Meconium aspiration syndrome.

Neonatal network : NN, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Meconium Aspiration Syndrome: An Insight.

Medical journal, Armed Forces India, 2010

Guideline

Meconium Staining in Newborns

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Meconium Aspiration Syndrome: A Narrative Review.

Children (Basel, Switzerland), 2021

Research

Meconium aspiration syndrome: historical aspects.

Journal of perinatology : official journal of the California Perinatal Association, 2008

Guideline

Management of Meconium Aspiration Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the most likely diagnosis for a post-term newborn with a history of fetal distress, meconium-stained amniotic fluid, tachypnea, and respiratory distress, with chest X-ray showing hyperinflated lungs and patchy infiltrates?
What is the most appropriate management for an infant born with meconium aspiration and severe respiratory distress, with a chest X-ray (CXR) showing patchy infiltrates?
What are the symptoms and implications of meconium aspiration syndrome (MAS) in a newborn, particularly if delivered via cesarean section (C-section)?
What is the immediate management for a newborn who aspirates meconium (meconium aspiration syndrome) after delivery?
What's the next step for a newborn with respiratory distress, abnormal breathing pattern, tachypnea, hypoxemia, and meconium staining?
What are the precautions for using Lexapro (escitalopram) and Lunesta (eszopiclone) in patients with sleep apnea?
Does exercise, including both cardio and resistance training, help reduce diastolic blood pressure (DBP)?
What is the most appropriate initial investigation for a patient presenting with depression, loss of appetite, social isolation, and substance use (specifically marijuana) to relieve stress, who also exhibits anxiety and non-adherence to depression medication?
What adjustments can be made to a patient with diabetes' insulin regimen, currently on glargine (insulin glargine) and lispro (insulin lispro), to manage hyperglycemia with morning blood glucose levels of 244 mg/dL?
Should asymptomatic Helicobacter pylori (H. pylori) infection be treated?
What is the appropriate diagnosis and treatment for a patient presenting with stuttering, anxiety, and depression that started 6 days prior to presentation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.